Skip to main content
. 2011 Jun 16;52(7):4263–4273. doi: 10.1167/iovs.10-7103

Figure 1.

Figure 1.

RGC-5 cells expressed RGC markers. RGC-5 cells were plated in eight-well chamber slides, treated overnight with 2.0 μM SS, and immunostained with antibodies against Brn3a and Thy-1. The results showed that the RGC-5 cells differentiated after SS treatment and expressed Brn3a and Thy-1, markers characteristic of RGCs. Magnification, ×40.